Acknowledgement
This study was supported by a grant from the Korea Advanced Research Program through the National Research Foundation of Korea (NRF), which is funded by the Ministry of Science and ICT, Republic of Korea (grant No. 2020M3H8A1115041) and a grant from the Asan Medical Center (grant No. AMC-2022IL0026).
References
- World Health Organization. WHO coronavirus (COVID-19) dashboard [Internet]. Available at https://covid19.who.int/ [accessed on 26 April 2022].
- Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA, Hernan MA, Lipsitch M, Reis B, Balicer RD. Bnt162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med 2021;384:1412-1423. https://doi.org/10.1056/NEJMoa2101765
- Abu-Raddad LJ, Chemaitelly H, Ayoub HH, AlMukdad S, Yassine HM, Al-Khatib HA, Smatti MK, Tang P, Hasan MR, Coyle P, et al. Effect of mRNA vaccine boosters against SARS-CoV-2 omicron infection in Qatar. N Engl J Med 2022;386:1804-1816. https://doi.org/10.1056/NEJMoa2200797
- Centers for Disease Control and Prevention US. COVID-19 vaccine boosters [Internet]. Available at https://www.cdc.gov/coronavirus/2019-ncov/vaccines/booster-shot.html [accessed on 26 April 2022].
- Benotmane I, Gautier-Vargas G, Cognard N, Olagne J, Heibel F, Braun-Parvez L, Martzloff J, Perrin P, Moulin B, Fafi-Kremer S, et al. Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine. Kidney Int 2021;99:1498-1500. https://doi.org/10.1016/j.kint.2021.04.005
- Rozen-Zvi B, Yahav D, Agur T, Zingerman B, Ben-Zvi H, Atamna A, Tau N, Mashraki T, Nesher E, Rahamimov R. Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study. Clin Microbiol Infect 2021;27:1173.e1-1173.e4. https://doi.org/10.1016/j.cmi.2021.04.028
- Grupper A, Rabinowich L, Schwartz D, Schwartz IF, Ben-Yehoyada M, Shashar M, Katchman E, Halperin T, Turner D, Goykhman Y, et al. Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus. Am J Transplant 2021;21:2719-2726. https://doi.org/10.1111/ajt.16615
- Cucchiari D, Egri N, Bodro M, Herrera S, Del Risco-Zevallos J, Casals-Urquiza J, Cofan F, Moreno A, Rovira J, Banon-Maneus E, et al. Cellular and humoral response after mRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients. Am J Transplant 2021;21:2727-2739. https://doi.org/10.1111/ajt.16701
- Rabinowich L, Grupper A, Baruch R, Ben-Yehoyada M, Halperin T, Turner D, Katchman E, Levi S, Houri I, Lubezky N, et al. Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients. J Hepatol 2021;75:435-438. https://doi.org/10.1016/j.jhep.2021.04.020
- Thuluvath PJ, Robarts P, Chauhan M. Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases. J Hepatol 2021;75:1434-1439. https://doi.org/10.1016/j.jhep.2021.08.008
- Ruether DF, Schaub GM, Duengelhoef PM, Haag F, Brehm TT, Fathi A, Wehmeyer M, Jahnke-Triankowski J, Mayer L, Hoffmann A, et al. SARS-CoV2-specific humoral and T-cell immune response after second vaccination in liver cirrhosis and transplant patients. Clin Gastroenterol Hepatol 2022;20:162-172.e9. https://doi.org/10.1016/j.cgh.2021.09.003
- Kim JY, Lim SY, Park S, Kwon JS, Bae S, Park JY, Cha HH, Seo MH, Lee HJ, Lee N, et al. Immune responses to the ChAdOx1 nCoV-19 and BNT162b2 vaccines and to natural coronavirus disease 2019 infections over a 3-month period. J Infect Dis 2022;225:777-784. https://doi.org/10.1093/infdis/jiab579
- Caillard S, Thaunat O. COVID-19 vaccination in kidney transplant recipients. Nat Rev Nephrol 2021;17:785-787. https://doi.org/10.1038/s41581-021-00491-7
- Nazaruk P, Monticolo M, Jedrzejczak AM, Krata N, Moszczuk B, Sanko-Resmer J, Pilecki T, Urbanowicz A, Florczak M, Paczek L, et al. Unexpectedly high efficacy of SARS-CoV-2 BNT162b2 vaccine in liver versus kidney transplant recipients-is it related to immunosuppression only? Vaccines (Basel) 2021;9:1454.
- Pahl MV, Vaziri ND. Chapter 24 - Immune function in chronic kidney disease. In: Kimmel PL, Rosenberg ME, eds. Chronic Renal Disease. San Diego, CA; Academic Press; 2015. p.285-297.
- He X, Smeets RL, Koenen HJ, Vink PM, Wagenaars J, Boots AM, Joosten I. Mycophenolic acid-mediated suppression of human CD4+ T cells: more than mere guanine nucleotide deprivation. Am J Transplant 2011;11:439-449. https://doi.org/10.1111/j.1600-6143.2010.03413.x
- Boyarsky BJ, Werbel WA, Avery RK, Tobian AA, Massie AB, Segev DL, Garonzik-Wang JM. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA 2021;325:2204-2206.
- Heidt S, Roelen DL, Eijsink C, Eikmans M, van Kooten C, Claas FH, Mulder A. Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help. Clin Exp Immunol 2010;159:199-207. https://doi.org/10.1111/j.1365-2249.2009.04051.x
- Wallin EF, Hill DL, Linterman MA, Wood KJ. The calcineurin inhibitor tacrolimus specifically suppresses human T follicular helper cells. Front Immunol 2018;9:1184.